Professional Documents
Culture Documents
Stephen V. Sobel
To Marilyn and Martin Sobel, my parents, whose love and support, showing me
the importance of hard work and giving me opportunities, have made everything
else possible. To Frances Brown, my wife, whose love, encouragement, reality
checks, compassion, and patience make it all worthwhile. To Ariel Sobel, our
daughter, whose love, creativity, drive, and passion to learn inspire me.
Contents
Acknowledgments
References
Index
Acknowledgments
This book would never have been possible without the very hard work of many
people and my good fortune to have been influenced by many wonderful people
in my life.
I first want to thank Deborah Malmud, vice president and the director of the
professional books division at W. W. Norton & Company, for her vision,
recognizing the need for a book to teach mental health and medical professionals
how to successfully choose and then use the medications we are fortunate to
have available to us, requesting that I write it, and having confidence in me to do
so. I want to thank Sophie Hagen, associate managing editor, for her dedicated
hard work bringing this book to completion. I appreciate the efforts and work of
all at Norton Professional Books who worked on this project. I also want to
thank my colleagues who served as advance readers of the manuscript for their
suggestions and kind comments.
A teacher is only as good as he has been taught, and I have had the good
fortune to receive an excellent education from the faculty who imparted
knowledge and taught me to think critically at Duke University and Vanderbilt
University School of Medicine, and those who mentored me during my
internship in medicine at Georgetown University and my residency in psychiatry
at the University of California, San Diego. I was lucky to have trained and
started my career as a psychiatrist at a unique moment that saw the explosion of
biological treatments, the decline in the supremacy of psychoanalysis, the
development of cognitive therapy, and the ascendancy of the biopsychosocial
model. I am indebted to my fellow classmates and colleagues who have
challenged and supported each other while responding to these changes over the
last 30 years.
I am thankful to have been invited to lecture to many thousands of our
colleagues in psychiatry and medicine over the last 20 years, allowing me to
hone my craft as a teacher. I have received invaluable feedback from the
attendees and fellow teachers. I especially want to thank all of the dedicated staff
at CMELLC and the United States Psychiatric and Mental Health Congress,
Medical Education Resources, CMEA, and the California Association for
Marriage and Family Therapists. I will be eternally grateful that the United
States Psychiatric and Mental Health Congress honored me as Teacher of the
Year.
I want to publicly thank my family and friends who have been patient with me
as I wrote this book. Most importantly, I want to thank the many thousands of
patients who have opened their lives to me, trusted me, and searched with me for
solutions to their problems. My patients have been among my very best and
certainly most influential teachers. Their statements such as “this is the best I
have felt in many years” are truly motivating in our search to get patients into
remission.
CHAPTER 1
An All-Pro and future Hall of Fame quarterback, the story goes, was once
asked, “What makes you such a great and successful quarterback? Is it your
strong arm so that you can throw the football out of the stadium? Is it your
pinpoint accuracy so that you can throw the ball exactly where you want to? Is it
that you have an All-Pro and future Hall of Fame wide receiver who would make
any quarterback look good?” He responded, “No. All of those are helpful. But
the reason that I am so successful is that I know exactly where the ball needs to
go on each play before anyone else on the field does.”
Patients come to see us suffering from mental illness. They want help. They
want joy, happiness, and freedom from anxiety. They want peace of mind. They
do not want them tomorrow. They want them yesterday. They do not know how
to get there or what we can do to help them. It is our job to understand what
needs to happen, what we need to do, and what our patients need to do. It is our
job to know where the ball needs to be thrown.
Psychiatry has a dark, dirty secret. It is not something that I learned in medical
school or residency. Other psychiatrists tell me they did not learn it that way
either. It is the definition of treatment response. Patients come to see us looking
for relief from their psychiatric symptoms. They are willing to do whatever we
ask, including taking medications. All they ask is for a treatment response. A
treatment response in psychiatry is defined as at least a 50% decrease in
symptoms. This means that if you come to see me for treatment sick as stink and
I get you to half as sick as stink, then I have done my job. But you are still half
as sick as stink. Response is no longer an acceptable goal of treatment. The goal
of treatment needs to be a complete remission of symptoms. If a patient comes to
see you for treatment of hypertension with a blood pressure of 200/120 and you
are able to decrease his blood pressure to 160/100, by this definition of treatment
response you would have done your job. But the patient would still be
hypertensive. You would not be satisfied with what you had accomplished. Your
goal would be to get him into the normal range, below 140/90, that is, into
remission.
Remission means a full resolution of symptoms plus a return to full function.
The patient’s mood is happy. He is calm and not irritable. He has good sleep and
energy. His concentration and memory are fine. His self-esteem is high and
solid. He is functioning well in all areas of his life: at home with his family,
doing leisure activities, at work and/or in school, with his friends. Remission
means being calm and handling stressors with the appropriate amount of worry.
Remission means a patient feels as well premenstrually as she does during the
rest of her cycle. Remission means the total absence of panic attacks and
agoraphobia. Remission means the cessation of intrusive thoughts and
compulsive behaviors. Remission means being able to sleep well without
experiencing nightmares, without having flashbacks, without having emotional
numbness, and being able to fully engage in activities without avoidance.
Remission means being able to attend and enjoy social functions. Remission
means being able to speak at meetings at work with confidence and success.
Remission means being able to fall asleep, stay asleep, and wake up feeling
refreshed with good energy during the entire day. Remission means a stable
euthymic mood without periods of depression, hypomania, or mania. Remission
means freedom from the positive symptoms of psychosis, from hallucinations,
delusions, paranoia, and agitation. It also means freedom from the negative
symptoms of psychosis, from apathy, anhedonia, and dysphoria. Remission
means having good self-esteem, pride in your appearance, healthy eating, a
healthy weight, and the ability to express feelings instead of stuffing them with
food, alcohol, or drugs.
Too often the goal of treatment of psychiatric disease is to get a treatment
response, to help the patient feel better. This is not adequate. Our goal has to be
to get patients into remission. Failure to get patients into remission leads to a
greater risk of relapse. A study was done evaluating patients 3 months after they
started treatment for major depression.1 They were divided into a group who had
attained remission and a group who had responded but were not in remission.
Over the following 2 years, the patients who had responded but not remitted
were three times more likely to have a relapse or recurrence of major depression
than those who were in remission. Failure to achieve remission leads to
continued psychosocial limitations including impairments at home, at work, and
at play. It worsens the prognosis of other medical disorders, the comorbid Axis
III disorders. Failure to achieve remission leads to an increased utilization of
medical services, not only for the psychiatric disorder but for all disorders.
Failure to achieve remission leads to suicide. It leads to abuse of alcohol and
drugs. Our goal has to be to get patients into remission.
This, however, is very difficult to achieve. For example, over 3,600 patients
suffering from major depression were treated with antidepressants in the Star*D
study.2 This is the largest study of major depression ever conducted. All patients
were treated initially with the antidepressant Celexa at a solid mean dose of 47
mg. After 12 weeks, only 30% had achieved remission.
The purpose of this book is to teach you how you can help your patients
achieve remission. I want you to share their joy and happiness. It is based upon
the premise that all mental health, in the most symptomatic, impaired individual
and in the most mentally healthy individual, is caused by a combination of
biopsychosocial factors. It is based upon the premise that we need to recognize
and understand these factors, their interactions, and how to correct them. You
can get your patients into remission. I have written this book to teach you how to
choose and use psychotropic medications to address the biological etiology of
psychiatric disease and mental health. I have written this book to help you
understand the key aspects of psychotherapy in order to deal with the
psychosocial factors that you need to know to use these medications within the
context of the patient’s life. I have written this book to help you become a
successful psychopharmacologist.
There is a story about a company whose entire business revolved around one
machine. One day, the machine broke. The employees ran to the manager,
screaming, “Our machine has broken! What we are going to do?” The manager
said, “Don’t worry. I know what to do. I’ll call the fix-it guy.” The fix-it guy
arrived carrying a huge suitcase full of tools. He put it down, opened it up, and
spread out all the tools. He walked over to the machine. He walked around it
once, twice, three times. He walked over to the manager and said, “I know what
to do.” He walked over to his tools, grabbed a huge hammer, walked back to the
machine, and, boom, hit it with his hammer. The machine roared back to life.
The employees cheered and gathered around him, clapping him on the back,
hugging him, and thanking him for saving their company. The manager walked
over and the employees separated. He walked up to the fix-it guy and said,
“Thank you so much. You have saved our company.” The fix-it guy replied, “No
problem. Here’s my bill.” The manager looked at the bill, looked up at the fix-it
guy, looked down the bill, and then looked up again, saying, “Ten thousand
dollars. You are charging $10,000? All you did was hit it with a hammer.” The
fix-it guy paused, looked the manager in the eyes, and replied, “Hitting it with a
hammer was free. Knowing where, how, and when to hit it with the hammer,
that is what cost you $10,000.”
Successful psychopharmacologists know where, how, and when to use
psychotropic medications. We know what medications to use for what disorders,
what doses to use to get patients into remission, when to use them, when to
change them, when to combine them, and when to stop them. Like this machine,
our patients feel “broken.” It is not easy for them to ask for help. Society still
stigmatizes patients who suffer from psychiatric disease. People too often still
believe that psychiatric symptoms are a result of a personality weakness or a
character flaw. It takes courage to acknowledge to others that they are suffering
from psychiatric symptoms. They turn to us to help them “get their machines
running.” We need to learn where, how, and when to do so.
The focus of this book is to help you understand what successful
psychopharmacologists do to get patients into remission. It is based upon the
premise that our work needs to be empirically based, that is, based upon
evidence that has been painstakingly gathered through scientific research.
However, it recognizes that there are tremendous gaps in this evidence. Our
decisions, therefore, cannot be made solely on the basis of available scientific
research but must also be based upon the lessons and understanding we have
gained from our experience. We will look at key studies that teach us important
concepts and further our ability to successfully treat patients. We will look, not
at all the studies that have been conducted, but at the ones that are clinically
most important and that help illustrate and clarify key clinical concepts. We will
combine this with the knowledge that we have learned from our treatment of
patients and directly from patients themselves. Successful psychopharmacology
combines evidence-based medicine with clinical experience, acumen, and
judgment.
If you are a psychiatrist who recognizes daily the challenges involved in
treating patients suffering from psychiatric disease and wants to learn the clinical
knowledge that will allow you to be a more successful psychopharmacologist,
please read on. If you are a primary care physician who recognizes the impact of
psychiatric disease on the lives of your patients and wants to be able to more
successfully treat your patients and to raise the quality of mental health treatment
to get your patients into remission, please read on. If you are a nurse or a
physician’s assistant who wants a more sophisticated and complete
understanding of psychopharmacology and wants to be able to help physicians
get your patients into remission, please read on. If you are a psychotherapist
frustrated by the quality of your associated psychiatrist’s or other physician’s
work and want to be able to advocate more successfully on your clients’ behalf,
please read on. If you are a patient suffering from psychiatric disease and
desperately want the joy, happiness, and contentment of remission that you
deserve, and you need a better understanding of psychopharmacology to be able
to talk with your physician more assertively and successfully, please read on.
As our All-Pro NFL Hall of Fame quarterback told us, the key to success
involves knowing where the ball needs to be thrown. Let’s start throwing this
football.
CHAPTER 2
Our goal is to relieve suffering, eliminate symptoms, and restore patients to their
highest level of function. Do not target symptoms when treating psychiatric
disorders. Instead, target the underlying neurotransmitter system abnormalities
that are causing these symptoms.
If your patient is anxious, depressed, irritable, impulsive, and/or obsessive,
target serotonin. If your patient is tired, anhedonic, and unmotivated with
problems concentrating, target norepinephrine. We believe depression is
associated with abnormalities or inefficiency of these monoamine systems. If
your patient has an anxiety disorder, target serotonin and/or gamma-
aminobutyric acid (GABA). Target the neural pathways involved in psychiatric
disease. If your patient has positive symptoms of psychosis including
hallucinations, delusions, paranoia, and agitation, target the excess dopaminergic
activity of the mesolimbic pathway. If your patient has the negative symptoms of
psychosis including apathy, anhedonia, depression, and lack of motivation,
target the underactive dopaminergic activity of the mesocortical pathway. If your
patient has bipolar disorder, target the excess kindling activity of the limbic
system or target dopamine. Use medications to increase BDNF (brain-derived
neurotrophic factor), to prevent neurodegeneration. Take a full and complete
history that allows you to identify the neurotransmitters and neural pathways
involved and then choose psychotropic medications to successfully impact those
neurotransmitters and/or pathways.
Too often physicians instead target symptoms. This can lead to an endless
search for medications to treat symptoms, then to treat side effects, often being
uncertain whether the problem is a symptom or side effect.
Let me illustrate this problem. A patient came to see me complaining of
depression, anxiety, fatigue, insomnia, and cognitive difficulties. She told me
she was taking six different psychotropic medications. Upon seeing my quizzical
expression, she said, “Let me explain. I went to my doctor complaining of
depression. He put me on Prozac 20 mg. I got anxious so he added Xanax 0.5
mg three times a day. I got tired so he added Adderall 10 mg twice daily. Then I
had trouble sleeping so he added Ambien 10 mg at bedtime. I became irritable
and he said it might be bipolar disorder, so he added Depakote 500 mg twice
daily. I started to gain weight so he added Topamax 100 mg at bedtime to stop
the weight gain. I’m a little bit better, but not a lot, and now I’m taking all these
medications.” This is an example of the polypharmacy that can occur when
physicians target symptoms rather than the underlying neurotransmitter
abnormalities. I carefully took a detailed history, diagnosed major depression,
tapered her off of all six medications and began her on a different selective
serotonin reuptake inhibitor (SSRI). She needed high doses but she achieved full
remission.
Not all patients require treatment with psychotropic medications. But if you
believe the patient does need a medication, use it assertively and effectively.
Start with a low dose when possible to decrease the risk of side effects
developing. Then increase the dose. Start low and go slow, especially for
patients who are anxious about medications. But do not stay low. Go to whatever
dose is necessary. Some major depressions will remit on 75 mg of Effexor XR or
20 mg of Celexa; some bipolar disorders will stabilize on lithium with a level of
0.5 mEq/L and some psychoses will remit on 1 mg of Risperdal. But not many.
Some disorders, such as panic disorder, obsessive-compulsive disorder, and
bulimia, tend to require high doses of medications. Do not be afraid to use these
medications at the doses needed for remission. Be assertive. Start low, go slow,
but go.
TREAT TO REMISSION
Our goal must be to fully eliminate symptoms, fully relieve suffering, and bring
patients to their full maximum function, that is, to remission. Do not settle for a
partial response.
Be careful to avoid the “pretty good syndrome.” Patients generally want to
please us. They will not always tell us how much they are suffering. They may
be so relieved to have a partial response with symptom decrease that they are
afraid to rock the boat. They don’t want to disappoint us. The pretty good
syndrome occurs when you ask your patient, “How are you feeling?” and he
responds, “Pretty good.” Ask more detailed questions and you will regularly find
that “pretty good” actually means “pretty bad” with continued significant
symptoms. Successful psychopharmacologists never give up. We constantly are
searching for better and better results—that is, full remission. A patient who
suffers from a major depression superimposed upon a dysthymic disorder needs
to be told, “The goal of treatment is for you to come into my office and say, ‘I
have never felt this good my entire life.’” Do not just resolve the symptoms of
the major depression and return him to his previous dysthymia. Treat him to
remission. A partially treated patient will continue to have problems in his
personal relationships, his work, and in his home and community. He will also
be more likely to have a recurrence of symptoms. Treat to remission.
How long does the patient suffering from a psychiatric disorder need to take
medication? I have found that among the first questions most patients ask me is,
“Will I be on this medication for the rest of my life?” The answer, of course,
depends upon the nature of the disorder that we are treating.
A first episode of major depression requires treatment for 9 to 12 months. You
may have heard that only 4 to 6 months of treatment are necessary, but this
period starts only after the patient is in remission. A second episode of major
depression requires at least 1 to 2 years of treatment. A third episode indicates
maintenance, that is, lifelong, treatment. Use the “rule of one” to start with all
anxiety disorders; that is, treat anxiety disorders for 1 year, and then reevaluate.
Some patients may require maintenance treatment.
While it is not a hard-and-fast rule, the longer the disorder has gone on, the
longer the treatment tends to need to be. When tapering off medications, go
slowly. It is not a race. Educate your patient about symptoms of relapse or
recurrence. Explain that it is simply a matter of brain chemistry. If the patient’s
neurotransmitter systems and neural pathways are working well, he is unlikely to
experience any return of symptoms upon discontinuation of medication.
Remember that all psychiatric disorders are biopsychosocial in etiology. Choose
a time of low stress when attempting to taper off and discontinue medications.
Patients who suffer from bipolar disorder or schizophrenia require lifelong
maintenance treatment. Tell your patients that you understand that no one wants
to take medications for the rest of their lives. Remind them that the goal of
treatment is not to “get off of the medications,” but to lead a happy, content, full,
and productive life.
No matter how carefully and well you have chosen the medication and
developed a treatment plan, the patient will never get better if he does not adhere
to treatment. Understand that the majority of our patients are going to go off
medication within a few months of beginning them even if they are benefiting
from them. A number of studies have shown this. Unfortunately, only about 40%
of patients will take antidepressant medications for more than 3 months even
though we know that they need to take their antidepressant for at least 9 months
to 1 year if not longer. We know that fully two-thirds of patients will have
discontinued the antidepressant by 6 months. One study found that 13% of
patients never even filled the first prescription.6 Consequently, part of our
success has to do with being able to work together to maintain adherence and to
move the patient forward through the different factors that prevent it.
Taking medications daily is difficult. Patients forget. They hate the side
effects. They may struggle to afford it. They feel embarrassed and ashamed,
viewing their disorder as a character flaw or a personality weakness. They start
to feel well and do not believe they still need to take the medication or they feel
hopeless and do not believe any treatment will help. We all become frustrated
with patients who are not compliant with our treatment recommendations. Take
a moment to honestly acknowledge how you personally react to them. Do you
react with anger, sadness, and rejection; with empathy, sympathy, and
understanding; or with a mix of all of these? Why do you think you react in these
ways? Think about your personal history of medication noncompliance. We
have all “forgotten” to take doses of medications. What were your reasons for
being forgetful?
There are many reasons for treatment nonadherence. Dealing with this is
among the most challenging and frustrating parts of our work. Risk factors for
nonadherence include age, with a higher frequency among the very young and
very old. Substance abuse and other comorbid psychiatric and medical disorders
increase nonadherence. Socioeconomic barriers including lower income and less
education increase nonadherence. Patients taking medications without also
receiving psychotherapy are more likely to stop treatment.
Counter nonadherence with the two most effective strategies you have:
education and your therapeutic alliance. Educate patients about the nature of
their disorders and the benefits of treatment. Use motivational interviewing
strategies. Take patients through the stages of contemplating change,
determining to make change, making the change, and maintaining the change.
Take a complete history. Patients are more likely to have confidence in and
adhere to your treatment recommendations if they believe that the
recommendations are based on a thorough evaluation. Personalize treatment,
taking into consideration patient preferences. Be empathic. Understand your
patient’s treatment goals. Her primary goal, for example, may be to get a good
night’s sleep while your goal is to successfully treat her anxiety disorder. Help
her recognize that insomnia is a symptom of anxiety. Addressing both at the first
appointment will be more effective than focusing primarily on her anxiety. You
want her to understand that you understand her situation and pain. Stay vigilant
and monitor the therapeutic relationship. See patients regularly and frequently.
Having to look you in the eye and admit to not taking medication decreases the
likelihood that it will occur. Involve patients in the process of making a
diagnosis, developing a treatment plan, and selecting medication. Educated
patients are good patients who are much more likely to reach remission.
Encourage them to research their diseases and treatments. Direct them toward
good medical scientific Web sites. Warn patients about the misinformation and
poor advice found often on message boards and in chat rooms.
So much trouble in cotreatment occurs before we ever see the patient. Therefore,
I tell therapists that work with me, “Please call or send me a brief note. I don’t
care how you want to do it. Just find a way to communicate with me, please. We
don’t necessarily need to actually talk live by phone or in person. I want to know
why you are referring this patient to me. Are you referring the patient to me
because he is suicidal? Because you just saw him and you just read this book
where I said medication and psychotherapy were better than psychotherapy
alone? Because your supervisor said you’d better get a psychiatrist on board in
case something terrible happens? Because you are getting ready to go on
vacation and you aren’t sure who’s going to cover for you, so you’ll ask me to
do it? What’s the reason for the referral?” Many patients walk into my office and
when I ask, “Why are you here?” they respond, “Um, because my therapist said I
had to.” This is not a good start to my treatment. I tell therapists, “I want to
know what your diagnostic impression is. What do you think this patient has?
What’s your diagnosis? Let me know specifically what you think. Obviously, is
the patient suicidal? Is the patient homicidal? Is she abusing substances?” It’s
crucial to know. I recall a patient sent to me for treatment of panic disorder. The
patient lied to me about drug and alcohol abuse. I prescribed an SSRI and a
benzodiazepine, then received a call from the therapist, who yelled, “How dare
you prescribe a benzodiazepine to this patient?” I responded, “What are you
talking about?” The therapist said, “Don’t you know he’s still in alcohol rehab?”
I said, “No, I didn’t know that. I asked. The patient lied. Why didn’t you tell me
before I saw him?”
We have to communicate to be successful. It needs to be based upon mutual
and earned respect, so use voice mail, e-mail, or snail mail, but please remember,
just mail.
Discover the patient’s level of acceptance of the referral. This is crucial and is
one thing the therapist often forgets to talk about. Know how motivated the
patient is for referral. If I know ahead of time that she does not trust nor want
medications, as soon as she comes into my office, I say very simply, “Unless
you beg me, I will not be writing you a prescription today. So the pressure is off.
We’re simply going to talk about your options and then you can come back next
week for treatment if you want.” It makes for a much greater opportunity for a
therapeutic alliance to develop and dramatically increases the likelihood that she
will ask for a prescription. More often than not, she requests a prescription and
we have established a therapeutic relationship in which she feels heard.
Know about Axis II disorders, because the Axis II disorder may be very thing
that prevents the Axis I disorder from getting better. Learn about any history of
abuse, neglect, and victimization, because these will color how the patient views
you.
I see increasing reason to believe that the view formed some time
back as to the origin of the Makonde bush is the correct one. I have
no doubt that it is not a natural product, but the result of human
occupation. Those parts of the high country where man—as a very
slight amount of practice enables the eye to perceive at once—has not
yet penetrated with axe and hoe, are still occupied by a splendid
timber forest quite able to sustain a comparison with our mixed
forests in Germany. But wherever man has once built his hut or tilled
his field, this horrible bush springs up. Every phase of this process
may be seen in the course of a couple of hours’ walk along the main
road. From the bush to right or left, one hears the sound of the axe—
not from one spot only, but from several directions at once. A few
steps further on, we can see what is taking place. The brush has been
cut down and piled up in heaps to the height of a yard or more,
between which the trunks of the large trees stand up like the last
pillars of a magnificent ruined building. These, too, present a
melancholy spectacle: the destructive Makonde have ringed them—
cut a broad strip of bark all round to ensure their dying off—and also
piled up pyramids of brush round them. Father and son, mother and
son-in-law, are chopping away perseveringly in the background—too
busy, almost, to look round at the white stranger, who usually excites
so much interest. If you pass by the same place a week later, the piles
of brushwood have disappeared and a thick layer of ashes has taken
the place of the green forest. The large trees stretch their
smouldering trunks and branches in dumb accusation to heaven—if
they have not already fallen and been more or less reduced to ashes,
perhaps only showing as a white stripe on the dark ground.
This work of destruction is carried out by the Makonde alike on the
virgin forest and on the bush which has sprung up on sites already
cultivated and deserted. In the second case they are saved the trouble
of burning the large trees, these being entirely absent in the
secondary bush.
After burning this piece of forest ground and loosening it with the
hoe, the native sows his corn and plants his vegetables. All over the
country, he goes in for bed-culture, which requires, and, in fact,
receives, the most careful attention. Weeds are nowhere tolerated in
the south of German East Africa. The crops may fail on the plains,
where droughts are frequent, but never on the plateau with its
abundant rains and heavy dews. Its fortunate inhabitants even have
the satisfaction of seeing the proud Wayao and Wamakua working
for them as labourers, driven by hunger to serve where they were
accustomed to rule.
But the light, sandy soil is soon exhausted, and would yield no
harvest the second year if cultivated twice running. This fact has
been familiar to the native for ages; consequently he provides in
time, and, while his crop is growing, prepares the next plot with axe
and firebrand. Next year he plants this with his various crops and
lets the first piece lie fallow. For a short time it remains waste and
desolate; then nature steps in to repair the destruction wrought by
man; a thousand new growths spring out of the exhausted soil, and
even the old stumps put forth fresh shoots. Next year the new growth
is up to one’s knees, and in a few years more it is that terrible,
impenetrable bush, which maintains its position till the black
occupier of the land has made the round of all the available sites and
come back to his starting point.
The Makonde are, body and soul, so to speak, one with this bush.
According to my Yao informants, indeed, their name means nothing
else but “bush people.” Their own tradition says that they have been
settled up here for a very long time, but to my surprise they laid great
stress on an original immigration. Their old homes were in the
south-east, near Mikindani and the mouth of the Rovuma, whence
their peaceful forefathers were driven by the continual raids of the
Sakalavas from Madagascar and the warlike Shirazis[47] of the coast,
to take refuge on the almost inaccessible plateau. I have studied
African ethnology for twenty years, but the fact that changes of
population in this apparently quiet and peaceable corner of the earth
could have been occasioned by outside enterprises taking place on
the high seas, was completely new to me. It is, no doubt, however,
correct.
The charming tribal legend of the Makonde—besides informing us
of other interesting matters—explains why they have to live in the
thickest of the bush and a long way from the edge of the plateau,
instead of making their permanent homes beside the purling brooks
and springs of the low country.
“The place where the tribe originated is Mahuta, on the southern
side of the plateau towards the Rovuma, where of old time there was
nothing but thick bush. Out of this bush came a man who never
washed himself or shaved his head, and who ate and drank but little.
He went out and made a human figure from the wood of a tree
growing in the open country, which he took home to his abode in the
bush and there set it upright. In the night this image came to life and
was a woman. The man and woman went down together to the
Rovuma to wash themselves. Here the woman gave birth to a still-
born child. They left that place and passed over the high land into the
valley of the Mbemkuru, where the woman had another child, which
was also born dead. Then they returned to the high bush country of
Mahuta, where the third child was born, which lived and grew up. In
course of time, the couple had many more children, and called
themselves Wamatanda. These were the ancestral stock of the
Makonde, also called Wamakonde,[48] i.e., aborigines. Their
forefather, the man from the bush, gave his children the command to
bury their dead upright, in memory of the mother of their race who
was cut out of wood and awoke to life when standing upright. He also
warned them against settling in the valleys and near large streams,
for sickness and death dwelt there. They were to make it a rule to
have their huts at least an hour’s walk from the nearest watering-
place; then their children would thrive and escape illness.”
The explanation of the name Makonde given by my informants is
somewhat different from that contained in the above legend, which I
extract from a little book (small, but packed with information), by
Pater Adams, entitled Lindi und sein Hinterland. Otherwise, my
results agree exactly with the statements of the legend. Washing?
Hapana—there is no such thing. Why should they do so? As it is, the
supply of water scarcely suffices for cooking and drinking; other
people do not wash, so why should the Makonde distinguish himself
by such needless eccentricity? As for shaving the head, the short,
woolly crop scarcely needs it,[49] so the second ancestral precept is
likewise easy enough to follow. Beyond this, however, there is
nothing ridiculous in the ancestor’s advice. I have obtained from
various local artists a fairly large number of figures carved in wood,
ranging from fifteen to twenty-three inches in height, and
representing women belonging to the great group of the Mavia,
Makonde, and Matambwe tribes. The carving is remarkably well
done and renders the female type with great accuracy, especially the
keloid ornamentation, to be described later on. As to the object and
meaning of their works the sculptors either could or (more probably)
would tell me nothing, and I was forced to content myself with the
scanty information vouchsafed by one man, who said that the figures
were merely intended to represent the nembo—the artificial
deformations of pelele, ear-discs, and keloids. The legend recorded
by Pater Adams places these figures in a new light. They must surely
be more than mere dolls; and we may even venture to assume that
they are—though the majority of present-day Makonde are probably
unaware of the fact—representations of the tribal ancestress.
The references in the legend to the descent from Mahuta to the
Rovuma, and to a journey across the highlands into the Mbekuru
valley, undoubtedly indicate the previous history of the tribe, the
travels of the ancestral pair typifying the migrations of their
descendants. The descent to the neighbouring Rovuma valley, with
its extraordinary fertility and great abundance of game, is intelligible
at a glance—but the crossing of the Lukuledi depression, the ascent
to the Rondo Plateau and the descent to the Mbemkuru, also lie
within the bounds of probability, for all these districts have exactly
the same character as the extreme south. Now, however, comes a
point of especial interest for our bacteriological age. The primitive
Makonde did not enjoy their lives in the marshy river-valleys.
Disease raged among them, and many died. It was only after they
had returned to their original home near Mahuta, that the health
conditions of these people improved. We are very apt to think of the
African as a stupid person whose ignorance of nature is only equalled
by his fear of it, and who looks on all mishaps as caused by evil
spirits and malignant natural powers. It is much more correct to
assume in this case that the people very early learnt to distinguish
districts infested with malaria from those where it is absent.
This knowledge is crystallized in the
ancestral warning against settling in the
valleys and near the great waters, the
dwelling-places of disease and death. At the
same time, for security against the hostile
Mavia south of the Rovuma, it was enacted
that every settlement must be not less than a
certain distance from the southern edge of the
plateau. Such in fact is their mode of life at the
present day. It is not such a bad one, and
certainly they are both safer and more
comfortable than the Makua, the recent
intruders from the south, who have made USUAL METHOD OF
good their footing on the western edge of the CLOSING HUT-DOOR
plateau, extending over a fairly wide belt of
country. Neither Makua nor Makonde show in their dwellings
anything of the size and comeliness of the Yao houses in the plain,
especially at Masasi, Chingulungulu and Zuza’s. Jumbe Chauro, a
Makonde hamlet not far from Newala, on the road to Mahuta, is the
most important settlement of the tribe I have yet seen, and has fairly
spacious huts. But how slovenly is their construction compared with
the palatial residences of the elephant-hunters living in the plain.
The roofs are still more untidy than in the general run of huts during
the dry season, the walls show here and there the scanty beginnings
or the lamentable remains of the mud plastering, and the interior is a
veritable dog-kennel; dirt, dust and disorder everywhere. A few huts
only show any attempt at division into rooms, and this consists
merely of very roughly-made bamboo partitions. In one point alone
have I noticed any indication of progress—in the method of fastening
the door. Houses all over the south are secured in a simple but
ingenious manner. The door consists of a set of stout pieces of wood
or bamboo, tied with bark-string to two cross-pieces, and moving in
two grooves round one of the door-posts, so as to open inwards. If
the owner wishes to leave home, he takes two logs as thick as a man’s
upper arm and about a yard long. One of these is placed obliquely
against the middle of the door from the inside, so as to form an angle
of from 60° to 75° with the ground. He then places the second piece
horizontally across the first, pressing it downward with all his might.
It is kept in place by two strong posts planted in the ground a few
inches inside the door. This fastening is absolutely safe, but of course
cannot be applied to both doors at once, otherwise how could the
owner leave or enter his house? I have not yet succeeded in finding
out how the back door is fastened.